Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Clene Inc., (NASDAQ: CLNN)

Emerging Growth Conference
9.19K subscribers
313 views 10 months ago
Clene Inc., (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. Keynote speaker: Rob Etherington, President / CEO, & Morgan Brown, CFO ...more
...more
Clene Inc., (NASDAQ: CLNN)
7Likes
313Views
Jul 182024
Clene Inc., (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. Keynote speaker: Rob Etherington, President / CEO, & Morgan Brown, CFO

Follow along using the transcript.

Emerging Growth Conference

9.19K subscribers